investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Shalendar Bhasin
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Shalendar Bhasin
Brigham and Women's Hospital
Boston, United States
Related projects
Yue Wu
Deprive prostate cancer of DHEAS to prevent castration-recurrent prostate cancer
Prostate
Robert L Comis
ECOG-ACRIN Operations Center
Prostate
Sanjeev Shukla
Natural Agent in Prevention of Prostate Cancer
Prostate
Mark A Rubin
Molecular Signatures of Lethal and Indolent Prostate Cancer
Prostate
Pathology
Ian M Thompson
San Antonio Center for Biomarkers of Risk For Prostate Cancer (SABOR)
Prostate
Pathology
Kathryn M Wilson
Bone Metabolism and Bone Metastases in Prostate Cancer
Prostate
Pathology
Norman Wolmark
NRG Oncology Network Group Operations Center
Prostate
Radiation Oncology
Surgery / Surgical oncology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Prostate
Stephen N Thibodeau
Prostate Cancer Susceptibility: The ICPCG Study
Prostate
Pathology